Basic principles in preclinical cancer chemotherapy.
N Brock, J Pohl, B Schneider
No abstract text available.
- Arzneimittelforschung. 1958 Jan;8(1):1-9
[PMID: 13510143]
- Cancer Res. 1973 Jun;33(6):1150-8
[PMID: 4718666]
- Cancer Treat Rev. 1983 Sep;10 Suppl A:163-4
[PMID: 6414689]
- Z Krebsforsch. 1967;69(2):103-201
[PMID: 4230610]
- Methods Find Exp Clin Pharmacol. 1987 Sep;9(9):589-94
[PMID: 3437788]
- Cancer Treat Rev. 1985 Mar;12(1):1-47
[PMID: 3896483]
- Eur J Cancer Clin Oncol. 1987 Jul;23(7):937-48
[PMID: 3665999]
- MMW Munch Med Wochenschr. 1975 Aug 22;117(34):1345-8
[PMID: 52114]
- Cancer Chemother Rep. 1966 May;50(4):173-218
[PMID: 5938250]
- Munch Med Wochenschr. 1958 Dec 5;100(49):1913-8
[PMID: 13622529]
- Klin Wochenschr. 1952 Oct 1;30(37-38):882-4
[PMID: 13001136]
- Arzneimittelforschung. 1964 Mar;14:171-6
[PMID: 14235978]
- Med Welt. 1967 Jul 1;26:1573-8
[PMID: 5616188]
- Cancer Treat Rep. 1976 Apr;60(4):445-9
[PMID: 1277220]
- Mol Pharmacol. 1971 Sep;7(5):519-29
[PMID: 5139563]
- Biochem Pharmacol. 1974 Jan 1;23(1):115-29
[PMID: 4811053]
- Science. 1977 Jul 29;197(4302):461-3
[PMID: 560061]
- Cancer Treat Rep. 1976 Apr;60(4):327-35
[PMID: 1277208]
- Cancer Treat Rep. 1987 Jan;71(1):1-2
[PMID: 3791263]
- Med Klin. 1961 Aug 25;56:1421-30
[PMID: 13724502]
- Cancer. 1984 Sep 15;54(6 Suppl):1229-38
[PMID: 6467150]
- Nature. 1966 May 21;210(5038):866-7
[PMID: 5958471]
- Cancer Treat Rep. 1976 Apr;60(4):361-8
[PMID: 1277212]
- Arzneimittelforschung. 1980;30(7):1034-40
[PMID: 7191283]
- Cancer Treat Rev. 1983 Sep;10 Suppl A:83-92
[PMID: 6414699]
- Cancer Treat Rep. 1976 Apr;60(4):437-43
[PMID: 1277219]
- Cancer Treat Rev. 1985 Sep;12(3):155-62
[PMID: 3907827]
- J Cancer Res Clin Oncol. 1986;111(1):1-12
[PMID: 3949846]
- J Natl Cancer Inst. 1989 Jul 5;81(13):988-94
[PMID: 2659805]
- Med Welt. 1967 Apr 22;16:985-9
[PMID: 5585096]
- Biom Z. 1966;8(3):147-61
[PMID: 5183162]
- Cancer Invest. 1988;6(5):513-32
[PMID: 3063337]
- N Engl J Med. 1978 Jun 15;298(24):1321-7
[PMID: 77475]
- Prog Clin Biol Res. 1988;276:265-86
[PMID: 3051021]
- Recent Results Cancer Res. 1986;103:36-40
[PMID: 3461512]
- J Natl Cancer Inst. 1990 Jan 17;82(2):96-101
[PMID: 2403594]
- Semin Oncol. 1982 Dec;9(4 Suppl 1):2-7
[PMID: 6761865]
- Semin Oncol. 1981 Dec;8(4):349-61
[PMID: 7323809]
- Adv Pharmacol Chemother. 1984;20:1-20
[PMID: 6398966]
- Verh Dtsch Ges Rheumatol. 1972;2:Suppl 2:339-57
[PMID: 5051958]
- Dtsch Med Wochenschr. 1975 Aug 29;100(35):1719-26
[PMID: 1098886]
- Arzneimittelforschung. 1976;26(10):1783-92
[PMID: 798586]
- J Cancer Res Clin Oncol. 1979 Sep;95(1):39-42
[PMID: 91617]
Animals
Antineoplastic Agents
Cyclophosphamide
Dose-Response Relationship, Drug
Drug Evaluation, Preclinical
Ifosfamide
Mechlorethamine
Mice
Neoplasms
Nitrogen Mustard Compounds
Rats
Antineoplastic Agents
Nitrogen Mustard Compounds
Mechlorethamine
Cyclophosphamide
trofosfamide
nornitrogen mustard
Ifosfamide